Medicare beneficiaries may engage with a multitarget stool DNA test such as Cologuard better than a fecal immunochemical test. Read more.
Thompson Health Gastroenterology relocated to a new outpatient clinic May 4.
The American Gastroenterological Association released a guideline on the consultative management of COVID-19 patients. Read more.
CellMax Life released results from its U.S. study of the FirstSight blood test that revealed the test detected colorectal cancer with 100 percent sensitivity at 90 percent specificity.
Phoenix-based Arizona Digestive Health expects patient volumes in May will be just a fraction of what they were before the pandemic.
RDD Pharma, Innovate Biopharmaceuticals and Naia Rare Diseases merged and formed 9 Meters Biopharma, which will develop treatments for orphan diseases and unmet needs in gastroenterology.
More articles on surgery centers:
Life after ramp-up: How COVID-19 will change ASCs forever
3 ASC nurses join COVID-19 front lines in New York
4 hospitals, health systems opening ASCs
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
